Sun Pharma must immediately declare a voluntary recall of Levipil 500
Dr Avi Chaudhuri, expert on anti-counterfeiting has further analysed the recent counterfeiting case of Sun Pharma’s Levipil 500.…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Guest Blogs
Building a pharma-ready logistics network: The need for compliance, speed, and scalability
In the article, Nitesh Agarwal, President of CJ Darcl Logistics, outlines the critical infrastructure, regulatory, and…
Trump tariffs on the pharmaceutical sector. A new twist- the US department of commerce initiates a…
Ashwin Sapra highlights how the US Section 232 investigation into pharma imports marks a significant escalation in Trump-era trade…
Syngene collaborates with biotech firm to develop bile acid modulator for cholestatic disease…
On the occasion of World Liver Day, Jayashree Aiyar, Chief Scientific Officer, Syngene International shared her insights into a…
A troubling new development in India’s QR code saga
Dr Avi Chaudhuri, a global expert on anti-counterfeiting has written extensively on the deficits of the recently mandated QR…
The rise of Fixed-Dose Combinations (FDCs): What it means for pharma players
The author highlights how the growing popularity of Fixed-Dose Combinations (FDCs) presents both opportunities and regulatory…
Leading the change: Why companies must prioritise women in management
Arushi Jain, Director, Akums Drugs and Pharmaceuticals highlights how companies that promote women to leadership positions create…
Breaking barriers: Women in STEM lead the way
This Women’s Day, Women in STEM from Merck share trials and triumphs from their journeys and provide a message for the next…
Revamping multi-tier distribution: Ensuring consistent availability for India’s pharma growth
Chandrachur Datta, Partner, Vector Consulting Group explores how revamping the multi-tier distribution system with a demand-driven…
Leadership evolution in India’s pharma sector in 2025
As the sector adapts to technological advancements, regulatory requirements, and increasing competition, several leadership role…
Being complacent in pharma quality: Five minutes to midnight
Dr Sumedha Nadkar, Pharma Consultant and Visiting Faculty, shares a hard-hitting article which highlights that complacency in…
Leadership evolution in India’s pharmaceutical sector in 2025- Driving global growth and…
Tarunesh Madan highlights the evolving leadership landscape in Indian pharma, exploring emerging roles, global expansion…
From wellness to wealth: How Gen Y, Gen Z, and AI are driving mission $100 billion for India’s…
Vikas Bansi, Business Director- India OTC - Himalaya Wellness, Sailesh S, Partner, Anthill Ventures, Len Monheit, CEO, Industry…
Evolution and commercialisation of cell and gene therapies
Satyen Sanghavi, Founder & CSO, Regrow Biosciences traces the evolution of cell and gene therapies, highlighting global…
Laboratory bench to life: Connecting biotechnology and sustainability impact
Praanjal Agarwal, Associate Director - Technical & Innovation at Sustain Labs Paris, highlights how the gap between innovation…
Exemptions, concessional duty on essential medicines to improve drug access: Sudarshan Jain, IPA
Sudarshan Jain, Secretary General of Indian Pharmaceutical Alliance (IPA) opines that by prioritising drug accessibility, robust…
Some gaps in Union Budget 2025, but positive policy-level clarifications: Anil Matai, OPPI
Anil Matai, Director General, OPPI observes that while some gaps remain, OPPI is committed to facilitating and partnering with the…
Union Budget 2025-26: A roadmap for India’s pharmaceutical leadership
Dr Satish Wagh, Executive Chairman & Whole-Time Director, Supriya Lifesciences urges focused reforms in R&D, regulatory…
Understanding opportunities and challenges for SMEs after breather on Schedule M deadline
Akshansh Chaudhary, Executive Director & Chief Technical Officer, Venus Remedies highlights the challenges SMEs face and how…
Bolstering India’s healthcare innovation in cancer, rare diseases: How Budget 2025 can make a…
Amit Mookim, CEO, Immuneel Therapeutics urges the govt to focus on establishing a strong compliance framework and expediting…